Biotechnology - Denmark

Filter

Current filters:

Denmark

Popular Filters

Genmab reports nine month interim results, including $31 million revenue increase on 2013

Genmab reports nine month interim results, including $31 million revenue increase on 2013

06-11-2014

Danish biotech company Genmab has reported its nine-month interim results, including an increase in revenue…

BiotechnologydaratumumabDenmarkDuoBodyFinancialGenmabOfatumumab Injection

Norgine provides over $8 million to Azanta to fund clinical development pipeline

Norgine provides over $8 million to Azanta to fund clinical development pipeline

13-10-2014

Norgine Ventures, the business entity of privately-owned European pharma company Norgine, has provided…

Azanta DanmarkBiotechnologyBusiness FinanceDenmarkNorgine

Clear conditions for biosimilars the best way to boost patient safety says Danish Pharmaceutical Association

Clear conditions for biosimilars the best way to boost patient safety says Danish Pharmaceutical Association

06-10-2014

When treating patients, patient safety is crucial. Regardless of whether this concerns biological, biosimilar…

BiosimilarsBiotechnologyDenmarkPharmacologyRegulation

Denmark’s Forward Pharma plans IPO

Denmark’s Forward Pharma plans IPO

02-10-2014

Denmark-based Forward Pharma A/S today announced it has commenced an underwritten initial public offering…

BiotechnologyDenmarkFinancialForward PharmaImmunologicals

Celgene's cancer drug Istodax could re-activate dormant HIV and allow it to be detected

Celgene's cancer drug Istodax could re-activate dormant HIV and allow it to be detected

23-07-2014

An anti-cancer drug developed by US biotech company Celgene Corp can re-activate dormant HIV which allows…

Aarhus UniversityAnti-viralsBiotechnologyCelgene Corp.DenmarkHIVHIV/AIDSIsodaxResearchromidepsin

Nuevolution signs international deal to screen potential cancer drugs using DNA tags

Nuevolution signs international deal to screen potential cancer drugs using DNA tags

22-01-2014

An innovative screening technology that tags compounds with unique strands of DNA will be used to assess…

BiotechnologyDenmarkNuevolutionOncologyResearchUK

Nuevolution signs licensing agreement with Novartis

Nuevolution signs licensing agreement with Novartis

10-01-2014

Denmark-based Nuevolution has entered into a non-exclusive technology licensing agreement with Swiss…

BiotechnologyDenmarkGeneticsLicensingNorthern EuropeNovartisNuevolutionResearch

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top